rss
Br J Ophthalmol doi:10.1136/bjo.2006.108795

Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal Bevacizumab therapy (Avastin).

  1. S K Gibran (syedgibran{at}yahoo.com),
  2. Arun Sachdev (arun_sachdev{at}hotmail.com),
  3. T Stappler (theodorstappler{at}web.de),
  4. R Newsome,
  5. David Wong (shdwong{at}liverpool.ac.uk),
  6. Paul Hiscott (p.s.hiscott{at}liverpool.ac.uk)
  1. St Paul's Eye Unit, United Kingdom
  2. St Pauls Eye Unit, United Kingdom
  3. St Paul's Eye Unit, United Kingdom
  4. Southampton General Hospital, United Kingdom
  5. St Paul's Eye Unit, United Kingdom
  6. St Paul's Eye Unit, United Kingdom
    • Published Online First 13 December 2006

    Abstract

    Aims: To report the findings in a patient treated by repeated intravitreal bevacizumab (Avastin®) injections followed by macular relocation and excision of sub-foveal choroidal neovascular membrane (CNV).

    Methods: Histopathological evaluation of the choroidal neovascular membrane (CNV) specimen, including immunohistochemical assessment.

    Results: During surgical excision the CNV appeared to be avascular and its underlying bed did not bleed. Histopathological examination revealed that the CNV comprised avascular fibrous subretinal tissue containing fibroblastic RPE cells, fragments of irregular thickened Bruch's membrane and fibrotic choroidal tissue containing some medium size vessels but no choriocapillaris.

    Conclusions: The development of an RPE rip during the course of avastin therapy may reflect contraction of the avascular subretinal tissue, while the lack of capillaries in both choroidal and subretinal components may be caused by the increased access of Avastin to the choriocapillaris in the presence of the RPE rip.

    Register for free content


    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.